TSHA(Taysha Gene Therapies, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-07-10 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 200,000 | $6.24 |
| 2026-04-10 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 200,000 | $4.46 |
| 2026-02-04 | Alam Kamran | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 1,655 | $4.52 |
| 2026-01-26 | Alam Kamran | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 23,849 | $4.61 |
| 2026-01-26 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 26,918 | $4.61 |
| 2026-01-26 | Nolan Sean P. | Chief Executive Officer | 公开市场卖出 | 41,312 | $4.61 |
| 2026-01-23 | Alam Kamran | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 78,968 | $4.75 |
| 2026-01-23 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 89,132 | $4.75 |
| 2026-01-23 | Nolan Sean P. | Chief Executive Officer | 公开市场卖出 | 136,789 | $4.75 |
| 2026-01-12 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 200,000 | $4.71 |
| 2025-12-01 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 260,047 | $4.51 |
| 2025-11-28 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 110,125 | $4.75 |
| 2025-09-10 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 200,000 | $3.23 |
| 2025-08-21 | Nagendran Sukumar | President and Head of R&D | 公开市场卖出 | 57,054 | $2.85 |
| 2025-08-21 | Alam Kamran | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 54,491 | $2.85 |
| 2025-05-30 | Manning Paul B | 10% 股东 | 公开市场买入 | 750,000 | $2.75 |